MedTrace Logo

Pharmacogenomic Study in Patients of Lung, Colorectal and Head/Neck Cancers Receiving Chemotherapy

NCT00442520 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2016-11-28

No results posted yet for this study

Summary

The purpose of this study is to look at several genes that might determine how the body processes the drugs used to treat lung, colorectal and head and neck cancers. The goal of this examination is to help investigators determine the proper dosage to give future cancer patients or to better predict which future patients will respond to particular drug therapies.

Conditions

Sponsors & Collaborators

  • Paul J. Patton Trust

    collaborator UNKNOWN

  • University of Kansas Medical Center

    lead OTHER

Principal Investigators

  • Yu-Jui Yvonne Wan, Ph.D. · University of Kansas Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2008-09-30
Completion
2008-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00442520 on ClinicalTrials.gov